Reagent assay Free Light Chain Kappa is a reliable and accurate test for measuring the levels of free light chains kappa in human urine samples.

Free light chains kappa are produced by plasma cells as part of the normal immune response, but they can also be elevated in various diseases such as multiple myeloma, amyloidosis, and chronic kidney disease.

Reagent assay Free Light Chain Kappa is designed for use on fully automatic laboratory use on Omlipo nephelometry analyzers, which offer high sensitivity, specificity, and throughput for clinical diagnostics.

Reagent assay Free Light Chain Kappa is based on the principle of immunonephelometry, which uses polyclonal antibodies to bind and form complexes with free light chains kappa in the sample. The complexes scatter light proportionally to their concentration and are detected by a photodetector.

Reagent assay Free Light Chain Kappa has been validated for performance characteristics such as linearity, precision, accuracy, stability, and interference. It has also been compared with other methods such as immunofixation electrophoresis and enzyme-linked immunosorbent assay.

Reagent assay Free Light Chain Kappa is a valuable tool for the diagnosis, prognosis, and monitoring of patients with plasma cell disorders and kidney diseases. It can also help to assess the response to treatment and the risk of disease progression or relapse.